FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39505211000001105: Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jun 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1791571000001111 Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1791581000001113 Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml Has AMP Xarelto 1mg/ml granules for oral suspension (Bayer Plc) true Inferred relationship Existential restriction modifier
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml Is a Rivaroxaban 1mg/ml oral suspension sugar free 250 ml true Inferred relationship Existential restriction modifier
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml Has specific active ingredient Rivaroxaban true Inferred relationship Existential restriction modifier
Xarelto 1mg/ml granules for oral suspension (Bayer Plc) 250 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start